166 related articles for article (PubMed ID: 32533406)
1. Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.
Ditsch N; Heublein S; Jeschke U; Sattler C; Kuhn C; Hester A; Czogalla B; Trillsch F; Mahner S; Engel J; Mayr D; Schmoeckel E
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1923-1932. PubMed ID: 32533406
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications.
Jerzak KJ; Cockburn J; Pond GR; Pritchard KI; Narod SA; Dhesy-Thind SK; Bane A
Breast Cancer Res Treat; 2015 Jan; 149(1):293-301. PubMed ID: 25542270
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor α1 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor.
Mohamed FEZA; Abdelaziz AO; Kasem AH; Ellethy T; Gayyed MF
Sci Rep; 2021 Apr; 11(1):7944. PubMed ID: 33846395
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.
Czogalla B; Deuster E; Liao Y; Mayr D; Schmoeckel E; Sattler C; Kolben T; Hester A; Fürst S; Burges A; Mahner S; Jeschke U; Trillsch F
Histochem Cell Biol; 2020 Oct; 154(4):421-429. PubMed ID: 32572587
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.
Zehni AZ; Batz F; Vattai A; Kaltofen T; Schrader S; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478016
[TBL] [Abstract][Full Text] [Related]
6. Glycodelin in ovarian serous carcinoma: association with differentiation and survival.
Mandelin E; Lassus H; Seppälä M; Leminen A; Gustafsson JA; Cheng G; Bützow R; Koistinen R
Cancer Res; 2003 Oct; 63(19):6258-64. PubMed ID: 14559812
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.
Browne A; Sriraksa R; Guney T; Rama N; Van Noorden S; Curry E; Gabra H; Stronach E; El-Bahrawy M
Cytokine; 2013 Oct; 64(1):413-21. PubMed ID: 23727325
[TBL] [Abstract][Full Text] [Related]
8. Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer.
Vogelsang TLR; Vattai A; Schmoeckel E; Kaltofen T; Chelariu-Raicu A; Zheng M; Mahner S; Mayr D; Jeschke U; Trillsch F
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445181
[TBL] [Abstract][Full Text] [Related]
9. Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients.
Deuster E; Mayr D; Hester A; Kolben T; Zeder-Göß C; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212758
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer.
Ciucci A; Zannoni GF; Travaglia D; Petrillo M; Scambia G; Gallo D
Gynecol Oncol; 2014 Feb; 132(2):351-9. PubMed ID: 24378878
[TBL] [Abstract][Full Text] [Related]
11. Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer.
McGrath SE; Annels N; Madhuri TK; Tailor A; Butler-Manuel SA; Morgan R; Pandha H; Michael A
BMC Cancer; 2018 Oct; 18(1):943. PubMed ID: 30285763
[TBL] [Abstract][Full Text] [Related]
12. Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.
Muller P; Coates PJ; Nenutil R; Trcka F; Hrstka R; Chovanec J; Brychtova V; Vojtesek B
J Ovarian Res; 2019 Mar; 12(1):30. PubMed ID: 30917858
[TBL] [Abstract][Full Text] [Related]
13. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
[TBL] [Abstract][Full Text] [Related]
14. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
Ho SM; Lau KM; Mok SC; Syed V
Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
[TBL] [Abstract][Full Text] [Related]
15. The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism.
Elliott MJ; Jerzak KJ; Cockburn JG; Safikhani Z; Gwynne WD; Hassell JA; Bane A; Silvester J; Thu KL; Haibe-Kains B; Mak TW; Cescon DW
Sci Rep; 2018 Nov; 8(1):16562. PubMed ID: 30410118
[TBL] [Abstract][Full Text] [Related]
16. Nuclear survivin is associated with malignant potential in epithelial ovarian carcinoma.
Qian X; Xi X; Li L
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):126-32. PubMed ID: 20724919
[TBL] [Abstract][Full Text] [Related]
17. beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.
Lee CM; Shvartsman H; Deavers MT; Wang SC; Xia W; Schmandt R; Bodurka DC; Atkinson EN; Malpica A; Gershenson DM; Hung MC; Lu KH
Gynecol Oncol; 2003 Mar; 88(3):363-8. PubMed ID: 12648588
[TBL] [Abstract][Full Text] [Related]
18. EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer.
Czogalla B; Kuhn C; Heublein S; Schmöckel E; Mayr D; Kolben T; Trillsch F; Burges A; Mahner S; Jeschke U; Hester A
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2519-2527. PubMed ID: 31485769
[TBL] [Abstract][Full Text] [Related]
19. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.
Syed V; Ulinski G; Mok SC; Ho SM
J Natl Cancer Inst; 2002 Apr; 94(8):617-29. PubMed ID: 11959895
[TBL] [Abstract][Full Text] [Related]
20. Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma.
Darb-Esfahani S; Sinn BV; Weichert W; Budczies J; Lehmann A; Noske A; Buckendahl AC; Müller BM; Sehouli J; Koensgen D; Györffy B; Dietel M; Denkert C
Histopathology; 2010 May; 56(6):727-39. PubMed ID: 20546338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
